tradingkey.logo
tradingkey.logo
Buscar

ReShape Lifesciences Inc

RSLS
Añadir a la lista de seguimiento
3.920USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
10.29MCap. mercado
PérdidaP/E TTM

Más Datos de ReShape Lifesciences Inc Compañía

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

Información de ReShape Lifesciences Inc

Símbolo de cotizaciónRSLS
Nombre de la empresaReShape Lifesciences Inc
Fecha de salida a bolsaOct 06, 2016
Director ejecutivoMr. Paul F. Hickey
Número de empleados17
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 06
Dirección1001 Calle Amanecer
CiudadSAN CLEMENTE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92673
Teléfono19494296680
Sitio Webhttps://www.reshapelifesciences.com/obalon/
Símbolo de cotizaciónRSLS
Fecha de salida a bolsaOct 06, 2016
Director ejecutivoMr. Paul F. Hickey

Ejecutivos de ReShape Lifesciences Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Mohanjit Jolly
Mr. Mohanjit Jolly
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de ReShape Lifesciences Inc?

Los cinco principales accionistas de ReShape Lifesciences Inc son: Mr. Krishna Gupta

¿Cuántas instituciones poseen acciones de ReShape Lifesciences Inc (RSLS)?

A fecha de 2026Q1, 34 instituciones poseen acciones de ReShape Lifesciences Inc, con un valor de mercado combinado de aproximadamente 207.69K, lo que representa el 2.96% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 148618.00.